Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 20% ± 5% | |
dendritic cell | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of FAHD2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1171.39 | 1445 / 1445 | 100% | 6.79 | 183 / 183 |
liver | 100% | 3832.33 | 226 / 226 | 100% | 14.09 | 406 / 406 |
ovary | 100% | 2027.68 | 180 / 180 | 100% | 10.31 | 430 / 430 |
pancreas | 100% | 1383.06 | 328 / 328 | 100% | 7.60 | 178 / 178 |
stomach | 100% | 1445.97 | 359 / 359 | 100% | 7.19 | 286 / 286 |
skin | 100% | 1587.76 | 1808 / 1809 | 100% | 14.60 | 472 / 472 |
thymus | 100% | 3998.06 | 653 / 653 | 100% | 14.44 | 604 / 605 |
prostate | 100% | 1553.03 | 245 / 245 | 100% | 9.93 | 501 / 502 |
brain | 100% | 2042.55 | 2636 / 2642 | 100% | 14.89 | 705 / 705 |
intestine | 100% | 1534.11 | 966 / 966 | 100% | 8.14 | 525 / 527 |
uterus | 100% | 1854.52 | 170 / 170 | 100% | 9.75 | 457 / 459 |
kidney | 100% | 1658.31 | 89 / 89 | 100% | 8.90 | 897 / 901 |
breast | 100% | 1883.77 | 459 / 459 | 100% | 8.77 | 1113 / 1118 |
bladder | 100% | 1196.43 | 21 / 21 | 99% | 8.49 | 500 / 504 |
lung | 99% | 1158.61 | 573 / 578 | 100% | 8.85 | 1155 / 1155 |
adrenal gland | 100% | 1294.19 | 258 / 258 | 98% | 7.69 | 226 / 230 |
adipose | 100% | 1535.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 17.60 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.89 | 29 / 29 |
spleen | 100% | 1328.77 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.22 | 1 / 1 |
muscle | 100% | 1453.66 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1154.33 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1289.72 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 56% | 547.48 | 519 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046872 | Molecular function | metal ion binding |
GO_0016787 | Molecular function | hydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FAHD2A |
Protein name | Fumarylacetoacetate hydrolase domain-containing protein 2A (EC 3.-.-.-) Fumarylacetoacetate hydrolase domain containing 2A |
Synonyms | CGI-105 |
Description | FUNCTION: May have hydrolase activity. . |
Accessions | ENST00000709682.1 C9J5B6 ENST00000418606.1 ENST00000709680.1 ENST00000233379.9 ENST00000445649.1 C9JGM0 ENST00000447036.5 Q96GK7 |